-
Product Insights
Metastatic Prostate Cancer – Drugs In Development, 2023
Global Markets Direct’s, ‘Metastatic Prostate Cancer - Drugs In Development, 2023’, provides an overview of the Metastatic Prostate Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development for Metastatic Prostate Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.